LPCN - Lipocine Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 570.31M
Enterprise Value 366.79M
Trailing P/E N/A
Forward P/E 16.15
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)
Price/Book (mrq)7.11
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-5.57

Trading Information

Stock Price History

Beta (3Y Monthly) 0.03
52-Week Change 385.99%
S&P500 52-Week Change 33.10%
52 Week High 33.4500
52 Week Low 31.0400
50-Day Moving Average 32.5194
200-Day Moving Average 32.0475

Share Statistics

Avg Vol (3 month) 3149.75k
Avg Vol (10 day) 3225.17k
Shares Outstanding 524.84M
Float 22.91M
% Held by Insiders 15.21%
% Held by Institutions 18.84%
Shares Short (Aug 15, 2019) 448.59k
Short Ratio (Aug 15, 2019) 40.42
Short % of Float (Aug 15, 2019) 40.21%
Short % of Shares Outstanding (Aug 15, 2019) 40.20%
Shares Short (prior month Jul 15, 2019) 454.12k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-33.35%
Return on Equity (ttm)-104.00%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-4.22M
EBITDA -11.98M
Net Income Avi to Common (ttm)-12.34M
Diluted EPS (ttm)-0.5510
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.48M
Total Cash Per Share (mrq)0.58
Total Debt (mrq)8.72M
Total Debt/Equity (mrq)88.50
Current Ratio (mrq)4.42
Book Value Per Share (mrq)0.40

Cash Flow Statement

Operating Cash Flow (ttm)-11.15M
Levered Free Cash Flow (ttm)-6.88M